Abstract
Measures of incidence are essential for investigating etiology. For congenital diseases and disorders of early childhood, birth year cohort prevalence serves the purpose of incidence. There is uncertainty and controversy regarding the birth prevalence trend of childhood disorders such as autism and intellectual disability because changing diagnostic factors can affect the rate and timing of diagnosis and confound the true prevalence trend. The etiology of many developmental disorders is unknown, and it is important to investigate. This paper presents a novel method, Time-to-Event Prevalence Estimation (TTEPE), to accurately estimate the time trend in birth prevalence of childhood disorders correctly adjusted for changing diagnostic factors. There is no known existing method that meets this need. TTEPE is based on established time-to-event (survival) analysis techniques. Input data are rates of initial diagnosis for each birth year cohort by age or, equivalently, diagnostic year. Diagnostic factors form diagnostic pressure, i.e., the probability of diagnosing cases, which is a function of diagnostic year. Changes in diagnostic criteria may also change the effective prevalence at known times. A discrete survival model predicts the rate of initial diagnoses as a function of birth year, diagnostic year, and age. Diagnosable symptoms may develop with age, affecting the age of diagnosis, so TTEPE incorporates eligibility for diagnosis. Parameter estimation forms a non-linear regression using general-purpose optimization software. A simulation study validates the method and shows that it produces accurate estimates of the parameters describing the trends in birth prevalence and diagnostic pressure. The paper states the assumptions underlying the analysis and explores optional additional analyses and potential deviations from assumptions. TTEPE is a robust method for estimating trends in true case birth prevalence controlled for diagnostic factors and changes in diagnostic criteria under certain specified assumptions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Corrected a couple of minor typos.
Data Availability
Data for this paper are generated by simulation software, which is available at https://doi.org/10.17605/OSF.IO/WPNKU
